Incruse Ellipta (Umeclidinium Bromide)

Incruse Ellipta Information:

Buy Incruse Ellipta

Incruse Ellipta (Umeclidinium Bromide) is used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). It is typically used to control symptoms associated with this condition and prevent acute exacerbation of COPD. It contains the active ingredient umeclidinium bromide, which is a long-acting muscarinic antagonist (LAMA). Umeclidinium works by blocking muscarinic receptors in the airway smooth muscle, inhibiting the action of acetylcholine, which results in bronchodilation and relaxation of the airway muscles. This mechanism helps to open the airways, improving airflow and reducing respiratory distress. This medication is not recommended for use in the management of acute attacks of chronic obstructive pulmonary disease.

Generic Incruse Ellipta from Canada

Canada Drugs Online proudly serves you the brand Incruse Ellipta, manufactured by GSK from Canada and the United Kingdom. The generic Incruse Ellipta is currently unavailable. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other medications for Asthma/respiratory disorders, such as Anoro Ellipta and Proair HFA.

Incruse Ellipta Side Effects:

Like other medicines, Incruse Ellipta may be associated with some mild side effects such as changed sense of taste, runny nose, nasal congestion, sore throat, constipation, cough, diarrhea, dizziness, dry mouth, headache, nausea, pain in the arm, leg, or back, mild stomach ache, and toothache. Contact your doctor if these mild side effects persist or worsen.

Possible serious side effects of this medicine may include fast or irregular heartbeat, joint or muscle pain, abnormal mental or mood changes, blurred vision, eye pain, shortness of breath, persistent cough, chest pain, difficulty or pain urinating, frequent urination, severe body itching, rash, swelling of your face, lips, tongue, or throat, and dizziness. If you observe these severe side effects, discontinue this medication and seek immediate medical attention. Additionally, inform your doctor about any other side effects not listed here.

Umeclidinium Bromide has been proven by various clinical trials to be an effective maintenance treatment option for chronic obstructive pulmonary disease, demonstrating superior efficacy to some other medications in its drug class. It is also generally well tolerated by most individuals, with its safety profile similar to other long-acting muscarinic antagonists (source).

Incruse Ellipta Directions:

Incruse Ellipta is administered via a dry powder inhaler, typically once daily, to ensure consistent therapeutic effects. Have your doctor or pharmacist explain how to use the inhaler and read the instructions carefully before using the inhaler. Your doctor will determine the appropriate dosage schedule for you. Try to use the inhaler at the same time every day for optimal effectiveness. Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.

Incruse Ellipta Precautions:

Before using this medication, it is essential to inform your doctor about any previous or current medical conditions you may have, especially the following:
• Allergic reactions to umeclidinium bromide, other ingredients of Incruse Ellipta, or any other medicine;
• Asthma;
• Diabetes;
• Electrolyte imbalance, such as low potassium levels;
• Eye conditions such as glaucoma;
• Heart disease, including arrhythmias;
• Liver disease;
• Seizure disorders;
• Thyroid problems;
• Urinating difficulties

This medicine should not be used to relieve acute COPD flare-ups. If you find you need to use your short-acting ("rescue") inhaler more often, or if your condition seems to worsen, call your doctor. Also, if you get tightness of the chest, coughing, wheezing, or breathlessness immediately after using your Incruse Ellipta inhaler: seek urgent medical help immediately. Avoid smoking while taking this medication to prevent side effects and to prevent worsening of your symptoms. This medicine should not be used during pregnancy or while breastfeeding unless recommended by your doctor. It is not recommended for use in individuals younger than 18 years. Some medications may interact with umeclidinium, leading to an increase in the risk of developing side effects. Some of these medications include:
• Antihistamines;
• Cyclobenzaprine;
• Glucagon;
• Quinidine;
• Revefenacin;
• Sofpironium

Therefore, before using this medication, inform your doctor about any other medications you are currently taking, including herbal and other inhaled medicines, to determine if it is safe to use along with Incruse Ellipta.